BioSpace News Archive

Marrone Bio Innovations, Inc., an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, released a letter to shareholders from Chief Executive Officer, Kevin Helash.

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2020 on Thursday, March 25, 2021.

Charles River Laboratories International, Inc. announced that it has closed its previously announced offering of $500 million in aggregate principal amount of its 3.750% senior notes due 2029 and $500 million in aggregate principal amount of its 4.000% senior notes due 2031 in an unregistered offering.

Labcorp continues to make progress executing our strategy and capitalizing on the power of our diagnostic and drug development businesses.

Fluidra, a global leader in pool and wellness equipment, has been selected to be part of the prestigious IBEX 35 index, produced by BME.

Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace & defense and industrial markets, reported net sales of $104.1 million for the year ended December 31, 2020, a decline of 10.5% compared to $116.3 for fiscal 2019

SwanBio Therapeutics, a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological conditions, today announced that Marita James, CPA, has been appointed as the company’s Chief Financial Officer.

Akoya Biosciences, Inc., The Spatial Biology Company ® , today announced its support for the Human Cell Atlas (HCA) initiative, offering the CODEX ® solution’s single-cell, whole-tissue imaging capabilities to HCA members under favorable commercial terms.

The national plaintiffs’ law firm Berger Montague is pleased to announce that the U.S. District Court in New Jersey has just issued a 121 page opinion and order in the Allergan BIOCELL Textured Breast Implant Products Liability Litigation, No. 2:19-md-02921, MDL No. 2921 (D.N.J.),

-- Adaptive Platform Trial is Evaluating Drugs and Investigational Products in the Treatment of Critically Ill COVID-19 Patients --